As for the loss of BRCA2, the model for loss of BRCA1 loss in ovary had sufficient predictive power (PR-AUC-E = 0.3) in the other data set, suggesting that the model works independently of the metastatic capacity of the tumour (Supplementary file 1h). The gene discussed is BRCA2; the disease is neoplasm.